Summary: Cannabis (marijuana) and endocannabinoids affect several biological processes, including neuroprotection.
Summary: Several defects are more significant than impaired motor skills in making it unsafe for some people with Parkinson's disease to drive. These include errors in judgment, easy distractibility, and an inability to multitask.
Summary: Relatives of patients with Parkinson's disease are more likely than others to develop symptoms of dementia. Researchers propose the presence of shared risk factors.
Summary: An Israeli company hopes to market stem cell treatments for neuorological disorders such as Parkinson's disease. Instead of using embryonic stem cells, BrainStorm Cell Therapeutics uses stem cells from the bone marrow of adults.
Summary: People with Parkinson's disease (PD) have a lower pain threshold than their peers. However, in a clinical study, levodopa increased the pain threshold of subjects with PD compared with healthy subjects who receive the same dose.
Summary: Two cell enzymes cooperate to prevent a break-down of mitochondria which could otherwise lead to Parkinson's disease.
Summary: Dementia is patients with Parkinson's disease is distinctly different from symptoms in patients with Alzheimer's. Parkinson's patients tend to have poor attention, while Alzheimer's patients have worse memory.
Summary: Scientists at Emory University have developed a computer model that simulates how the nervous system communicates with muscles to move muscles and control balance.
Summary: Mutations in the glucocerebrosidase (GBA) gene nearly triple the likelihood of developing Parkinson's disease and double the risk of onset before age 50.
Summary: As life expectancy rises in the U.S., and as death rates for diseases like cancer and heart disease drop, more people will die of Parkinson's disease. It is now the 14th leading cause of death.
